ghk-cu dosage chart Injection (50mg) GHK-CU Peptide Dosage Chart: Complete

Products marked research use only may have uncertain identity, purity, potency, sterility, or storage

While the science behind KPV is compelling, theres still so much we dont know about the peptide and how it impacts humans

When used as part of CagriSema, the dosing schedule looked like this in trials: Weeks 04: 0.25 mg cagrilintide + 0.25 mg semaglutide Weeks 48: 0.5 mg + 0.5 mg Weeks 812: 1 mg + 1 mg Weeks 1216: 1.7 mg + 1.7 mg Week 16 onward: 2.4 mg + 2.4 mg (full maintenance dose) Until the medication is approved and prescribing information is finalized, any dosing decisions would only happen through participation in a clinical trial or, eventually, under the guidance of a healthcare provider

Qsymia and Contrave are other oral prescription options your provider may discuss depending on your goals and medical history